Stay updated on Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence.” The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:49:46.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:23:23.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the expected content. This makes the record inaccessible and prevents viewing the trial details.
    Difference
    20%
    Check dated 2026-09-22T23:54:15.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page shows Revision: v3.7.0 instead of v3.6.6, indicating a software update to the Study Details page. There are no observed changes to the study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-15T23:55:18.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.6 instead of v3.6.5. This reflects a minor maintenance update to the page.
    Difference
    0.0%
    Check dated 2026-09-01T20:21:54.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.5, replacing the previous v3.6.4; this indicates a new version of the page, likely reflecting minor updates rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-11T21:56:19.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.